correction to 30day FRN

49040

Federal Register / Vol. 86, No. 167 / Wednesday, September 1, 2021 / Notices

Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
301–496–8683, [email protected].
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; P50
Clinical Research Center Grant Review.
Date: November 4, 2021.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health, 6001
Executive Boulevard, Room 8351, Bethesda,
MD 20892, (301) 451–6339, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: August 27, 2021.
Miguelina Perez,
Program Analyst, Office Federal Advisory
Committee Policy.
[FR Doc. 2021–18854 Filed 8–31–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings

khammond on DSKJM1Z7X2PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Electronic Nicotine Delivery Systems
(ENDS): Population, Clinical and Applied
Prevention Research.
Date: October 1, 2021.
Time: 11:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).

VerDate Sep<11>2014

17:09 Aug 31, 2021

Jkt 253001

Contact Person: Pamela Jeter, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 10J08,
Bethesda, MD 20892, (301) 435–2591,
[email protected].
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Biobehavioral Medicine and Health
Outcomes Study Section.
Date: October 4–5, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mark A. Vosvick, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
Bethesda, MD 20892, (301) 402–4128,
[email protected].
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review;
Group Motor Function, Speech and
Rehabilitation Study Section.
Date: October 4–5, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, MSC 7848, Bethesda, MD
20892, 301–402–4411, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)

Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Study Section.
Date: October 29, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892 (Video-Assisted
Meeting).
Contact Person: Luis E. Dettin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892, (301) 827–8231,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)

Dated: August 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2021–18859 Filed 8–31–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose

Fmt 4703

Sfmt 4703

[FR Doc. 2021–18845 Filed 8–31–21; 8:45 am]
BILLING CODE 4140–01–P

National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request Electronic
Individual Development Plan (eIDP)
(National Eye Institute); Correction
National Institutes of Health,

HHS.

Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting

Frm 00069

Dated: August 26, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.

AGENCY:

National Institutes of Health

PO 00000

confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

ACTION:

Notice; correction.

The Department of Health and
Human Services, National Institutes of
Health published a Notice in the
Federal Register on August 26, 2021.
That Notice requires a correction in the
SUPPLEMENTARY INFORMATION section.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
SUMMARY:

E:\FR\FM\01SEN1.SGM

01SEN1

49041

Federal Register / Vol. 86, No. 167 / Wednesday, September 1, 2021 / Notices
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Cesar E. Perez-Gonzalez,
Training Director, Office of the
Scientific Director, National Eye
Institute, NIH, Building 31, Room 6A22,
MSC 0250, Bethesda, Maryland 20892
or call non-toll-free number (301) 451–
6763 or Email your request, including
your address to: [email protected].
Formal requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of August 26, 2021,
in FR Doc. 2021–18393, on page 47652, as
found within the SUPPLEMENTARY
INFORMATION section, within the Estimated
Annualized Burden Hours table for the
Number of Responses per Respondent
column total currently reads ‘‘150’’ and is
corrected to read: ‘‘450’’.
Daniel R. Hernandez,
NIH Federal Register Certifying Official,
National Institutes of Health.

Dated: August 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18860 Filed 8–31–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2021–18812 Filed 8–31–21; 8:45 am]
BILLING CODE 4140–01–P

Substance Abuse and Mental Health
Services Administration

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Agency Information Collection
Activities: Proposed Collection;
Comment Request

National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting

khammond on DSKJM1Z7X2PROD with NOTICES

Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases,
Special Emphasis Panel; Time Sensitive
Obesity.
Date: September 28, 2021.
Time: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Video
Meeting).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353,
6707 Democracy Boulevard, Bethesda, MD
20892–2542, (301) 594–8898, barnardm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
0361.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
Number of
respondents
(states/
jurisdictions)

Type of activity

TEDS Admission Data .........................................................

VerDate Sep<11>2014

18:03 Aug 31, 2021

Jkt 253001

PO 00000

Frm 00070

Responses
per
respondent

52

Fmt 4703

Sfmt 4703

of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Treatment Episode
Data Set (TEDS) (OMB No. 0930–
0335)—Extension
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting an extension to
collect the Treatment Episode Data Set
(TEDS) data collection (OMB No. 0930–
0335), which expires on April 30, 2022.
TEDS is a compilation of client-level
substance use treatment admission and
discharge data submitted by states on
clients treated in facilities that receive
state funds. SAMHSA is also requesting
an extension to collect the client-level
mental health admission and update/
discharge data (MH–TEDS/MH–CLD)
submitted by states on clients treated in
facilities that receive state funds (also
OMB No. 0930–0335).
TEDS/MH–TEDS/MH–CLD data are
collected to obtain information on the
number of admissions and updates/
discharges at publicly funded substance
use treatment and mental health
services facilities and on the
characteristics of clients receiving
services at those facilities.
TEDS/MH–TEDS/MH–CLD also
monitor trends in the demographic,
substance use, and mental health
characteristics of admissions. In
addition, several of the data elements
used to calculate performance measures
for the Substance Abuse Block Grant
(SABG) and Mental Health Block Grant
(MHBG) applications are collected
through the TEDS/MH–TEDS/MH–CLD.
Most states collect the TEDS/MH–
TEDS/MH–CLD data elements from
their treatment providers for their own
administrative purposes and are able to
submit a cross-walked extract of their
data to TEDS/MH–TEDS/MH–CLD. No
changes are expected in the TEDS/MH–
TEDS/MH–CLD data elements that are
collected.
Estimated annual burden for the
separate TEDS/MH–TEDS/MH–CLD
activities is as follows:
Total
responses

4

E:\FR\FM\01SEN1.SGM

208

01SEN1

Hours per
response
6.25

Total burden
hours
1,300